Explore more publications!
Business Journal of Indiana
Got News to Share?

Business Journal of Indiana: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Business Journal of Indiana.

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

Press releases published on October 24, 2025

Syndax Announces FDA Approval of Revuforj® (revumenib) in Adult and Pediatric Patients with Relapsed or Refractory NPM1 Mutated Acute Myeloid Leukemia
October 24, 2025

Syndax Announces FDA Approval of Revuforj® (revumenib) in Adult and Pediatric Patients with Relapsed or Refractory NPM1 Mutated Acute Myeloid Leukemia

Indeterminate GlobeNewswire
À venir… La Campagne nationale du coquelicot 2025 de la Légion
October 24, 2025

À venir… La Campagne nationale du coquelicot 2025 de la Légion

Indeterminate GlobeNewswire
Tensora Launched the First AI-Powered Layer 2 on BNB Chain — Bringing Decentralized Machine Intelligence On-Chain
October 24, 2025

Tensora Launched the First AI-Powered Layer 2 on BNB Chain — Bringing Decentralized Machine Intelligence On-Chain

Indeterminate GlobeNewswire
YCTF Industrial Hardware Agency Revolutionizes Supply Chain with Full-Category In-Stock Direct Supply, Offering 30% Cost Savings and 50% Faster Delivery — Trusted by 2,000+ Global Enterprises
October 24, 2025

YCTF Industrial Hardware Agency Revolutionizes Supply Chain with Full-Category In-Stock Direct Supply, Offering 30% Cost Savings and 50% Faster Delivery — Trusted by 2,000+ Global Enterprises

Indeterminate GlobeNewswire
Azurity Pharmaceuticals Announces FDA Approval of JAVADIN™ (clonidine hydrochloride) Oral Solution
October 24, 2025

Azurity Pharmaceuticals Announces FDA Approval of JAVADIN™ (clonidine hydrochloride) Oral Solution

Indeterminate GlobeNewswire
PMV Pharmaceuticals Announces Updated Rezatapopt Monotherapy Interim Data From Ongoing PYNNACLE Phase 2 Trial Across Multiple Solid Tumors With a TP53 Y220C Mutation
October 24, 2025

PMV Pharmaceuticals Announces Updated Rezatapopt Monotherapy Interim Data From Ongoing PYNNACLE Phase 2 Trial Across Multiple Solid Tumors With a TP53 Y220C Mutation

Indeterminate GlobeNewswire
BAK Battery Unveils New Phase of Solid-State Battery Tech at SAECCE 2025
October 24, 2025

BAK Battery Unveils New Phase of Solid-State Battery Tech at SAECCE 2025

Indeterminate GlobeNewswire
《Rebel Engine》於 Steam Next Fest 顯示強勁表現後，Snail Games 重點展示公司產品組合增長動能
October 24, 2025

《Rebel Engine》於 Steam Next Fest 顯示強勁表現後，Snail Games 重點展示公司產品組合增長動能

Indeterminate GlobeNewswire
Bittam Redefines Crypto Trading — Trade Smarter with 200× Leverage, Zero Slippage, No Fees, and Up to $3,000 in Rewards
October 24, 2025

Bittam Redefines Crypto Trading — Trade Smarter with 200× Leverage, Zero Slippage, No Fees, and Up to $3,000 in Rewards

Indeterminate GlobeNewswire
Double the Impact: 100% of Faulk Foundation Donations Go Directly to Families and Students in Need
October 24, 2025

Double the Impact: 100% of Faulk Foundation Donations Go Directly to Families and Students in Need

Indeterminate GlobeNewswire
Ankur Keswani Joins SEDA Experts, Bringing Deep Expertise in High-Yield and Distressed Credit, Bankruptcy, and Restructurings
October 24, 2025

Ankur Keswani Joins SEDA Experts, Bringing Deep Expertise in High-Yield and Distressed Credit, Bankruptcy, and Restructurings

Indeterminate GlobeNewswire
AI in Biotechnology Market to Reach $11.4 Billion by 2030
October 24, 2025

AI in Biotechnology Market to Reach $11.4 Billion by 2030

Indeterminate GlobeNewswire
Splendor ($SPLD) Begins Trading on LBank Following Network Launch
October 24, 2025

Splendor ($SPLD) Begins Trading on LBank Following Network Launch

Indeterminate GlobeNewswire
No KYC. 100x Leverage. $100 Welcome Bonus. Crypto Futures Trading Made Easy on BexBack.
October 24, 2025

No KYC. 100x Leverage. $100 Welcome Bonus. Crypto Futures Trading Made Easy on BexBack.

Indeterminate GlobeNewswire
MicroCloud Hologram Inc. Releases Hybrid Quantum-Classical Convolutional Neural Network, Achieving New Breakthrough in MNIST Multi-Class Classification
October 24, 2025

MicroCloud Hologram Inc. Releases Hybrid Quantum-Classical Convolutional Neural Network, Achieving New Breakthrough in MNIST Multi-Class Classification

Indeterminate GlobeNewswire
Evolving Treatment Landscape for Chronic Spontaneous Urticaria Highlights Significant Unmet Needs and Expanding Opportunities for Therapeutic Innovation
October 24, 2025

Evolving Treatment Landscape for Chronic Spontaneous Urticaria Highlights Significant Unmet Needs and Expanding Opportunities for Therapeutic Innovation

Indeterminate GlobeNewswire
Canatu grants license for commercial production of CNT pellicle membranes using CNT100 SEMI reactor
October 24, 2025

Canatu grants license for commercial production of CNT pellicle membranes using CNT100 SEMI reactor

Indeterminate GlobeNewswire
Homary Welcomes 2025 Winter Collection: Create Warmth with New Fire Pit Sets and Cozy TV Stands
October 24, 2025

Homary Welcomes 2025 Winter Collection: Create Warmth with New Fire Pit Sets and Cozy TV Stands

Indeterminate GlobeNewswire
Robin Energy Ltd. Announces Pricing of $7.0 Million Registered Direct Offering
October 24, 2025

Robin Energy Ltd. Announces Pricing of $7.0 Million Registered Direct Offering

Indeterminate GlobeNewswire
24/7 Market News: VENU Lauches National Ad Campaign to Ignite America’s Next Entertainment Boom
October 24, 2025

24/7 Market News: VENU Lauches National Ad Campaign to Ignite America’s Next Entertainment Boom

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions